DE3850335D1 - Antiretroviraler Castanosperminester. - Google Patents

Antiretroviraler Castanosperminester.

Info

Publication number
DE3850335D1
DE3850335D1 DE3850335T DE3850335T DE3850335D1 DE 3850335 D1 DE3850335 D1 DE 3850335D1 DE 3850335 T DE3850335 T DE 3850335T DE 3850335 T DE3850335 T DE 3850335T DE 3850335 D1 DE3850335 D1 DE 3850335D1
Authority
DE
Germany
Prior art keywords
antiretroviral
castanospermine ester
castanospermine
ester
aids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3850335T
Other languages
English (en)
Other versions
DE3850335T2 (de
Inventor
Paul S Liu
Terry L Bowlin
Sai P Sunkara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of DE3850335D1 publication Critical patent/DE3850335D1/de
Publication of DE3850335T2 publication Critical patent/DE3850335T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE3850335T 1987-09-29 1988-09-26 Antiretroviraler Castanosperminester. Expired - Fee Related DE3850335T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/102,070 US5004746A (en) 1987-09-29 1987-09-29 Anti-retroviral castanospermine esters

Publications (2)

Publication Number Publication Date
DE3850335D1 true DE3850335D1 (de) 1994-07-28
DE3850335T2 DE3850335T2 (de) 1994-10-13

Family

ID=22287973

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3850335T Expired - Fee Related DE3850335T2 (de) 1987-09-29 1988-09-26 Antiretroviraler Castanosperminester.

Country Status (12)

Country Link
US (1) US5004746A (de)
EP (1) EP0309952B1 (de)
JP (1) JP2761898B2 (de)
KR (1) KR960009416B1 (de)
AT (1) ATE107506T1 (de)
AU (1) AU614993B2 (de)
DE (1) DE3850335T2 (de)
DK (1) DK172788B1 (de)
ES (1) ES2058201T3 (de)
IE (1) IE64311B1 (de)
PH (1) PH24431A (de)
ZA (1) ZA887160B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0252962B1 (de) * 1985-12-23 1995-08-23 Fred Hutchinson Cancer Research Center Regulierung der retroviralen replikation, infektion und pathogenese
US4952585A (en) * 1988-12-15 1990-08-28 Merrell Dow Pharmaceuticals Inc. Castanospermine esters in the inhibition of tumor metastasis
AU628228B2 (en) * 1989-10-17 1992-09-10 Merrell Dow Pharmaceuticals Inc. Esters of castanospermine in the treatment of cerebral malaria
US5214050A (en) * 1989-10-17 1993-05-25 Merrell Dow Pharmaceuticals Inc. Esters of castanospermine in the treatment of cerebral malaria
GB8924292D0 (en) * 1989-10-27 1989-12-13 Novalal Ltd The production of a novel dimer chemical product"novo dimers"by the polymersation of indolizidine alkaloids using cyclo dextrin glucosyl transferase
US5028614A (en) * 1990-03-30 1991-07-02 Merrell Dow Pharmaceuticals Inc. Hydroxymethyl-indolizidines and quinolizidines and their use as α-glucosidase I inhibitors
GB9027433D0 (en) * 1990-12-18 1991-02-06 Merrell Dow Pharma Anti-herpes castanospermine esters
GB9303518D0 (en) * 1993-02-22 1993-04-07 Merrell Dow Pharma Combinations of retroviral inhibitors
US5939430A (en) * 1993-02-22 1999-08-17 Merrell Pharmaceuticals Inc. Combinations of retroviral inhibitors
US5959111A (en) * 1997-05-22 1999-09-28 Hoechst Marion Roussel, Inc. Process for preparing 6-0-monoesters of castanospermine
ES2212292T3 (es) * 1997-05-22 2004-07-16 Aventis Pharmaceuticals Inc. Procedimiento para preparar 6-0-monoesteres de castanospermina.
GB0110832D0 (en) * 2001-05-03 2001-06-27 Virogen Ltd Antiviral compounds
KR20070053229A (ko) * 2004-08-13 2007-05-23 미게닉스 인코포레이티드 헤파드나비리대 감염을 치료 또는 예방하기 위한 조성물 및방법
KR20070061879A (ko) * 2004-10-06 2007-06-14 미게닉스 인코포레이티드 카스타노스페르민을 포함하는 조합 항-바이러스 조성물 및그의 사용 방법
KR20090040906A (ko) * 2006-08-02 2009-04-27 유나이티드 세러퓨틱스 코오포레이션 바이러스 감염의 리포솜 치료
KR20100127842A (ko) * 2008-03-26 2010-12-06 유니버시티 오브 옥스퍼드 소포체 표적화 리포좀
CN102427804A (zh) * 2009-03-27 2012-04-25 牛津大学之校长及学者 降低胆固醇水平的脂质体
WO2021168483A2 (en) 2020-02-21 2021-08-26 Florida State University Research Foundation, Inc. Treatment of human coronavirus infections using alpha-glucosidase glycoprotein processing inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0252962B1 (de) * 1985-12-23 1995-08-23 Fred Hutchinson Cancer Research Center Regulierung der retroviralen replikation, infektion und pathogenese
ZA883925B (en) * 1987-06-08 1989-02-22 Merrell Dow Pharma Inhibitors of glycoprotein processing having anti-retroviral activity
CA1315276C (en) * 1987-07-02 1993-03-30 Paul S. Liu Castanospermine esters and glycosides
US4952585A (en) * 1988-12-15 1990-08-28 Merrell Dow Pharmaceuticals Inc. Castanospermine esters in the inhibition of tumor metastasis

Also Published As

Publication number Publication date
DE3850335T2 (de) 1994-10-13
AU2280288A (en) 1989-04-06
ATE107506T1 (de) 1994-07-15
KR890004701A (ko) 1989-05-09
IE64311B1 (en) 1995-07-26
ZA887160B (en) 1989-05-30
DK172788B1 (da) 1999-07-19
KR960009416B1 (en) 1996-07-19
JP2761898B2 (ja) 1998-06-04
AU614993B2 (en) 1991-09-19
JPH01106821A (ja) 1989-04-24
US5004746A (en) 1991-04-02
DK538888A (da) 1989-03-30
ES2058201T3 (es) 1994-11-01
EP0309952A3 (en) 1990-09-26
IE882933L (en) 1989-03-29
PH24431A (en) 1990-06-25
EP0309952B1 (de) 1994-06-22
EP0309952A2 (de) 1989-04-05
DK538888D0 (da) 1988-09-28

Similar Documents

Publication Publication Date Title
DE3850335D1 (de) Antiretroviraler Castanosperminester.
DK441786A (da) Nucleosider, der kan anvendes terapeutisk
GR880100248A (el) Ουσιες για την προφυλαξη και θεραπεια ρετροιογενην φλεγμωνων.
ES2125233T3 (es) Tratamiento de las infecciones retrovirales humanas con 2',3'-didesoxiinosina.
DE3851121D1 (de) Filamentlose Magnetron-Ionenquelle und Verwendungsverfahren.
EP0296573A3 (en) Novel nucleosides, their preparation and pharmaceutical novel nucleosides, their preparation and pharmaceutical compositions compositions
DE3875769D1 (de) Therapeutische nukleoside.
EP0295538A3 (de) Inhibitoren der Glykoprotein-Verarbeitung mit anti-retroviraler Aktivität
FI932847A0 (fi) HIV-proteasinhibitorer som aer anvaendbara foer behandling av aids
ATE126435T1 (de) Antiherpes-castanosperminester.
FI830523L (fi) Anti-inflammatoriska och/eller smaerta lindrande 2,3-diaryl-5-halotiofener
DE69004451D1 (de) Prophylaxe und Behandlung von Herpesvirus-Infektionen.
FI851365L (fi) Liposomer med inhalerbara allergener foer behandling av allergener, foerfarande foer deras framstaellning och dessa innehaollande laekemedel.
DE69015411D1 (de) 5,11-Dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one und -thione und deren Verwendung bei der Vorbeugung und und Behandlung von AIDS.
ATE124950T1 (de) Nucleosid-analoge.
GR880100196A (el) Υποκατεστημενα 1,3-διοξολαν-και 1,3-διοξαν-παραγωγα,μεθοδοι για την παρασκευη τους και η χρηση τους
NO900616L (no) Fremgangsmaate for fraksjonering av avlinger i industrieltraamateriale.
FI925209A (fi) Foerfarande foer framstaellning av terapeutiskt aktiva heterocykliskt substituerade foereningar

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MERRELL PHARMACEUTICALS INC. (N.D.GES.D. STAATES D

8339 Ceased/non-payment of the annual fee